Open access
Sep 2026
Crucial Role of Lymphocytes in the Therapeutic Efficacy of Dendritic Cell Immunotherapy for Advanced Hepatocellular Carcinoma
At present, immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) are used to treat advanced hepatocellular carcinoma (HCC), with limited therapeutic effects. Dendritic cell (DC) immunotherapy may be a feasible option following ICI/TKI therapy to increase patient survival. Seventy patients with HCC...
Wei-Chen Lee, Y. Lai, Hao-Chien Hung et al.
· International Journal of Mol... · 0 citations